{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:34:59Z","timestamp":1794494099909,"version":"4.9.1"},"reference-count":198,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222038"],"award-info":[{"award-number":["82222038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970259"],"award-info":[{"award-number":["81970259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502606"],"award-info":[{"award-number":["82502606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023-JCJQ-ZQ-001"],"award-info":[{"award-number":["2023-JCJQ-ZQ-001"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Outstanding Young Talents of National Defense Biotechnology","award":["01-SWKJYCJJ06"],"award-info":[{"award-number":["01-SWKJYCJJ06"]}]},{"name":"Chongqing Outstanding Youth Fund","award":["CSTB2022NSCQ-JQX0017"],"award-info":[{"award-number":["CSTB2022NSCQ-JQX0017"]}]},{"name":"2024 Chongqing Municipal Postdoctoral Research Project Special Funding Program","award":["2024CQBSHTB2010"],"award-info":[{"award-number":["2024CQBSHTB2010"]}]},{"name":"Military Clinical Key Specialty Construction Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The cytokine storm, a life-threatening systemic inflammatory syndrome, is the primary driver of multiorgan failure in different clinical situations, including severe infections, autoimmune diseases, chimeric antigen receptor (CAR) T cell immunotherapy for cancer, and genetic syndromes. This review focuses primarily on cytokine storms triggered by severe infections such as viral pneumonia and bacterial sepsis, and explores the underlying mechanisms of cytokine storms and potential therapeutic interventions. Cytokine storms are characterized primarily by the excessive release of proinflammatory cytokines, which are triggered by pathogen-associated molecular patterns (PAMPs), damage-associated molecular patterns (DAMPs), and PANoptosis, all of which activate immune signaling cascades. Amplification mechanisms involve positive feedback loops and the failure of negative feedback mechanisms, leading to uncontrolled inflammation. Like a pyrrhic victory, the excessive activation of the immune system eliminated invading pathogens but caused catastrophic damage due to multiple organ dysfunction syndrome (MODS), turning the life-saving response into a life-threatening war. Therapeutic strategies, including cytokine antagonists, Janus kinase (JAK) inhibitors, caspase inhibitors, glucocorticoids, and blood purification therapies, aim to interrupt the self-amplifying cycle of inflammation that propagates organ injury, thereby reducing MODS and mortality. Challenges include optimizing the treatment timing and patient stratification. Future research should focus on combination therapies and personalized medicine based on the heterogeneity of infections and sepsis. Advances in multiomics and targeted therapies provide new hope for managing infections and sepsis.<\/jats:p>","DOI":"10.1186\/s40779-025-00678-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:01:45Z","timestamp":1768176105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The \u201ccytokine storm\u201d in infection and sepsis: win the battle but lose the war"],"prefix":"10.1016","volume":"12","author":[{"given":"Jiang-Bo","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Cai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-9083","authenticated-orcid":false,"given":"Ling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"1","key":"678_CR1","volume":"11","author":"JQ Xu","year":"2024","unstructured":"Xu JQ, Zhang WY, Fu JJ, Fang XZ, Gao CG, Li C, et al. Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations. Mil Med Res. 2024;11(1):78.","journal-title":"Mil Med Res"},{"issue":"43","key":"678_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aax7969","volume":"5","author":"Y Liu","year":"2020","unstructured":"Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020;5(43):eaax7969.","journal-title":"Sci Immunol"},{"issue":"20","key":"678_CR3","first-page":"2430","volume":"141","author":"MD Jain","year":"2023","unstructured":"Jain MD, Smith M, Shah NN. How i treat refractory CRS and ICANS after CAR T-cell therapy. Blood. 2023;141(20):2430\u201342.","journal-title":"Blood"},{"issue":"3","key":"678_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.202406-1241OC","volume":"211","author":"RBE van Amstel","year":"2025","unstructured":"van Amstel RBE, Bartek B, Vlaar APJ, Gay E, van Vught LA, Cremer OL, et al. Temporal transitions of the hyperinflammatory and hypoinflammatory phenotypes in critical illness. Am J Respir Crit Care Med. 2025;211(3):347\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"678_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149-68.e17.","journal-title":"Cell"},{"issue":"8","key":"678_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","volume":"42","author":"R Karki","year":"2021","unstructured":"Karki R, Kanneganti TD. The \u2018cytokine storm\u2019: molecular mechanisms and therapeutic prospects. Trends Immunol. 2021;42(8):681\u2013705.","journal-title":"Trends Immunol"},{"issue":"4","key":"678_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-022-00785-2","volume":"23","author":"CA Schmitt","year":"2023","unstructured":"Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. COVID-19 and cellular senescence. Nat Rev Immunol. 2023;23(4):251\u201363.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"678_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","volume":"21","author":"JN Brudno","year":"2024","unstructured":"Brudno JN, Kochenderfer JN. Current understanding and management of CAR T cell-associated toxicities. Nat Rev Clin Oncol. 2024;21(7):501\u201321.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"678_CR9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","volume":"217","author":"FP Veras","year":"2020","unstructured":"Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129.","journal-title":"J Exp Med"},{"issue":"1","key":"678_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34560-7","volume":"13","author":"J Jia","year":"2022","unstructured":"Jia J, Wang M, Meng J, Ma Y, Wang Y, Miao N, et al. Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still\u2019s disease pathogenesis. Nat Commun. 2022;13(1):6804.","journal-title":"Nat Commun"},{"issue":"8","key":"678_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F M\u00fcller","year":"2024","unstructured":"M\u00fcller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, V\u00f6lkl S, et al. CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up. N Engl J Med. 2024;390(8):687\u2013700.","journal-title":"N Engl J Med"},{"issue":"4","key":"678_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/mt.2010.24","volume":"18","author":"RA Morgan","year":"2010","unstructured":"Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther. 2010;18(4):843\u201351.","journal-title":"Mol Ther"},{"issue":"6","key":"678_CR13","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/S1470-2045(23)00159-6","volume":"24","author":"H Ludwig","year":"2023","unstructured":"Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, et al. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network. Lancet Oncol. 2023;24(6):e255\u201369.","journal-title":"Lancet Oncol"},{"issue":"10235","key":"678_CR14","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"H Li","year":"2020","unstructured":"Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517\u201320.","journal-title":"Lancet"},{"key":"678_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155404","volume":"138","author":"P Thepmankorn","year":"2021","unstructured":"Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, et al. Cytokine storm induced by SARS-CoV-2 infection: the spectrum of its neurological manifestations. Cytokine. 2021;138:155404.","journal-title":"Cytokine"},{"issue":"5","key":"678_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41423-021-00665-0","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wu H, Yao X, Zhang D, Zhou Y, Fu B, et al. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell Mol Immunol. 2021;18(5):1305\u20137.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"678_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011128","volume":"19","author":"X Lin","year":"2023","unstructured":"Lin X, Fu B, Xiong Y, Xing N, Xue W, Guo D, et al. Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection. PLoS Pathog. 2023;19(1):e1011128.","journal-title":"PLoS Pathog"},{"issue":"5","key":"678_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, Vecchi\u00e9 A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319\u201329.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"678_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00679-0","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021;6(1):255.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"678_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011406","volume":"19","author":"C Huo","year":"2023","unstructured":"Huo C, Tang Y, Li X, Han D, Gu Q, Su R, et al. Melatonin alleviates lung injury in H1N1-infected mice by mast cell inactivation and cytokine storm suppression. PLoS Pathog. 2023;19(5):e1011406.","journal-title":"PLoS Pathog"},{"issue":"1","key":"678_CR21","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1080\/21505594.2022.2120951","volume":"13","author":"D Yao","year":"2022","unstructured":"Yao D, Bao L, Li F, Liu B, Wu X, Hu Z, et al. H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1\/3 activation are associated with pulmonary immunopathological damage. Virulence. 2022;13(1):1558\u201372.","journal-title":"Virulence"},{"issue":"4","key":"678_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1515\/cclm-2020-1761","volume":"59","author":"G Lippi","year":"2021","unstructured":"Lippi G, Plebani M. Cytokine \u201cstorm\u201d, cytokine \u201cbreeze\u201d, or both in COVID-19?. Clin Chem Lab Med. 2021;59(4):637\u20139.","journal-title":"Clin Chem Lab Med"},{"key":"678_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109462","volume":"135","author":"JR Kennedy","year":"2020","unstructured":"Kennedy JR. Phosphatidylserine\u2019s role in Ebola\u2019s inflammatory cytokine storm and hemorrhagic consumptive coagulopathy and the therapeutic potential of annexin V. Med Hypotheses. 2020;135:109462.","journal-title":"Med Hypotheses"},{"issue":"1","key":"678_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s42003-020-01543-7","volume":"4","author":"N Baillet","year":"2021","unstructured":"Baillet N, Reynard S, Perthame E, Hortion J, Journeaux A, Mateo M, et al. Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques. Commun Biol. 2021;4(1):27.","journal-title":"Commun Biol"},{"issue":"3","key":"678_CR25","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.cyto.2012.07.038","volume":"60","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Kuroda M, Sakashita N, Konishi M, Kaneda H, Igarashi N, et al. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. Cytokine. 2012;60(3):694\u2013700.","journal-title":"Cytokine"},{"key":"678_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127769","volume":"285","author":"C Yang","year":"2024","unstructured":"Yang C, Xu Q, Xie M, Tang Y, Hu Q, Heng H, et al. Enhancing resistance, but not virulence attributed to the high mortality caused by carbapenem-resistant Klebsiella pneumoniae. Microbiol Res. 2024;285:127769.","journal-title":"Microbiol Res"},{"issue":"1","key":"678_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12964-023-01041-3","volume":"21","author":"Y Guo","year":"2023","unstructured":"Guo Y, Zhang H, Lv Z, Du Y, Li D, Fang H, et al. Up-regulated CD38 by daphnetin alleviates lipopolysaccharide-induced lung injury via inhibiting MAPK\/NF-\u03baB\/NLRP3 pathway. Cell Commun Signal. 2023;21(1):66.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"678_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010395","volume":"25","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Hu Z, Li S, Fang R, Ono HK, Hu DL. Molecular characteristics and pathogenicity of staphylococcus aureus exotoxins. Int J Mol Sci. 2023;25(1):395.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"678_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14090595","volume":"14","author":"A Roetzer","year":"2022","unstructured":"Roetzer A, Model N, Laube J, Unterhumer Y, Haller G, Eibl MM. Functional and immunological studies revealed a second superantigen toxin in staphylococcal enterotoxin C producing Staphylococcus aureus strains. Toxins (Basel). 2022;14(9):595.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"678_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.celrep.2013.12.014","volume":"6","author":"P Kalantari","year":"2014","unstructured":"Kalantari P, DeOliveira RB, Chan J, Corbett Y, Rathinam V, Stutz A, et al. Dual engagement of the NLRP3 and AIM2 inflammasomes by Plasmodium-derived hemozoin and DNA during malaria. Cell Rep. 2014;6(1):196\u2013210.","journal-title":"Cell Rep"},{"issue":"1","key":"678_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04628-x","volume":"27","author":"Z Fan","year":"2023","unstructured":"Fan Z, Kernan KF, Qin Y, Canna S, Berg RA, Wessel D, et al. Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis. Crit Care. 2023;27(1):347.","journal-title":"Crit Care"},{"issue":"6","key":"678_CR32","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1073\/pnas.1820704116","volume":"116","author":"A Wang","year":"2019","unstructured":"Wang A, Pope SD, Weinstein JS, Yu S, Booth CJ, Medzhitov R. Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice. Proc Natl Acad Sci U S A. 2019;116(6):2200\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"678_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.annonc.2020.10.478","volume":"32","author":"ML Schubert","year":"2021","unstructured":"Schubert ML, Schmitt M, Wang L, Ramos CA, Jordan K, M\u00fcller-Tidow C, et al. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy. Ann Oncol. 2021;32(1):34\u201348.","journal-title":"Ann Oncol"},{"issue":"12","key":"678_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26642","volume":"64","author":"SJ Rotz","year":"2017","unstructured":"Rotz SJ, Leino D, Szabo S, Mangino JL, Turpin BK, Pressey JG. Severe cytokine release syndrome in a patient receiving PD-1-directed therapy. Pediatr blood cancer. 2017;64(12):e26642. https:\/\/doi.org\/10.1002\/pbc.26642.","journal-title":"Pediatr blood cancer"},{"issue":"2","key":"678_CR35","first-page":"146","volume":"142","author":"F Del Bufalo","year":"2023","unstructured":"Del Bufalo F, Becilli M, Rosignoli C, De Angelis B, Algeri M, Hanssens L, et al. Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed\/refractory BCP-ALL. Blood. 2023;142(2):146\u201357.","journal-title":"Blood"},{"issue":"1","key":"678_CR36","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41467-024-44990-0","volume":"15","author":"C Molina-L\u00f3pez","year":"2024","unstructured":"Molina-L\u00f3pez C, Hurtado-Navarro L, Garc\u00eda CJ, Angosto-Bazarra D, Vallejo F, Tapia-Abell\u00e1n A, et al. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1\u03b2 production. Nat Commun. 2024;15(1):1096.","journal-title":"Nat Commun"},{"issue":"23","key":"678_CR37","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u201373.","journal-title":"N Engl J Med"},{"issue":"12","key":"678_CR38","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.molmed.2020.09.012","volume":"26","author":"SS Cabler","year":"2020","unstructured":"Cabler SS, French AR, Orvedahl A. A cytokine circus with a viral ringleader: SARS-CoV-2-associated cytokine storm syndromes. Trends Mol Med. 2020;26(12):1078\u201385.","journal-title":"Trends Mol Med"},{"issue":"1 Pt 2","key":"678_CR39","first-page":"1216","volume":"25","author":"JL Ferrara","year":"1993","unstructured":"Ferrara JL, Abhyankar S, Gilliland DG. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplant Proc. 1993;25(1 Pt 2):1216\u20137.","journal-title":"Transplant Proc"},{"issue":"9","key":"678_CR40","first-page":"771","volume":"97","author":"N Aikawa","year":"1996","unstructured":"Aikawa N. Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults. Nihon Geka Gakkai Zasshi. 1996;97(9):771\u20137. Japanese.","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"678_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00003086-199101000-00002","volume":"262","author":"WB Coley","year":"1991","unstructured":"Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases, 1893. Clin Orthop Relat Res. 1991;262:3\u201311.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"678_CR42","first-page":"189","volume":"11","author":"KY Yuen","year":"2005","unstructured":"Yuen KY, Wong SSY. Human infection by avian influenza A H5N1. Hong Kong Med J. 2005;11(3):189\u201399.","journal-title":"Hong Kong Med J"},{"issue":"1","key":"678_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16\u201332.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"678_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","volume":"39","author":"XJ Guo","year":"2017","unstructured":"Guo XJ, Thomas PG. New fronts emerge in the influenza cytokine storm. Semin Immunopathol. 2017;39(5):541\u201350.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"678_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrclinonc.2018.20","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, Wierda W, Locke FL, Lin Y, et al. Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit \u2018ALL\u2019. Nat Rev Clin Oncol. 2018;15(4):218.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10223","key":"678_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"6","key":"678_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19. J Infect. 2020;80(6):607\u201313.","journal-title":"J Infect"},{"key":"678_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","volume":"15","author":"J Zindel","year":"2020","unstructured":"Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol. 2020;15:493\u2013518.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"678_CR49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211463","volume":"219","author":"M Rumpret","year":"2022","unstructured":"Rumpret M, von Richthofen HJ, Peperzak V, Meyaard L. Inhibitory pattern recognition receptors. J Exp Med. 2022;219(1):e20211463.","journal-title":"J Exp Med"},{"issue":"17","key":"678_CR50","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1182\/blood.2023019940","volume":"142","author":"P Burkard","year":"2023","unstructured":"Burkard P, Schonhart C, V\u00f6gtle T, K\u00f6hler D, Tang L, Johnson D, et al. A key role for platelet GPVI in neutrophil recruitment, migration, and NETosis in the early stages of acute lung injury. Blood. 2023;142(17):1463\u201377.","journal-title":"Blood"},{"issue":"1","key":"678_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-023-01430-7","volume":"8","author":"J Ma","year":"2023","unstructured":"Ma J, Li Y, Yang X, Liu K, Zhang X, Zuo X, et al. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):168.","journal-title":"Signal Transduct Target Ther"},{"issue":"7856","key":"678_CR52","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-021-03350-4","volume":"592","author":"LR Hollingsworth","year":"2021","unstructured":"Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, et al. DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation. Nature. 2021;592(7856):778\u201383.","journal-title":"Nature"},{"issue":"2","key":"678_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cell.2011.09.039","volume":"147","author":"E Kowalinski","year":"2011","unstructured":"Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell. 2011;147(2):423\u201335.","journal-title":"Cell"},{"issue":"4","key":"678_CR54","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024;57(4):752\u201371.","journal-title":"Immunity"},{"issue":"6","key":"678_CR55","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20172060","volume":"215","author":"A Kanneganti","year":"2018","unstructured":"Kanneganti A, Malireddi RKS, Saavedra PHV, Vande Walle L, Van Gorp H, Kambara H, et al. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. J Exp Med. 2018;215(6):1519\u201329.","journal-title":"J Exp Med"},{"issue":"4","key":"678_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","volume":"19","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19(4):197\u2013214.","journal-title":"Nat Rev Cancer"},{"key":"678_CR57","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Kanneganti TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641\u201357.","journal-title":"Comput Struct Biotechnol J"},{"issue":"74","key":"678_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo6294","volume":"7","author":"R Karki","year":"2022","unstructured":"Karki R, Lee S, Mall R, Pandian N, Wang Y, Sharma BR, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol. 2022;7(74):eabo6294.","journal-title":"Sci Immunol"},{"issue":"2","key":"678_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020803","volume":"23","author":"A Lazzaro","year":"2022","unstructured":"Lazzaro A, De Girolamo G, Filippi V, Innocenti GP, Santinelli L, Ceccarelli G, et al. The interplay between host defense, infection, and clinical status in septic patients: a narrative review. Int J Mol Sci. 2022;23(2):803.","journal-title":"Int J Mol Sci"},{"key":"678_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaf046","volume":"13","author":"F Liao","year":"2025","unstructured":"Liao F, Fan J, Wang R, Xu Z, Li Q, Bi W, et al. Neutrophil extracellular traps in sepsis: trade-off between pros and cons. Burns Trauma. 2025;13:tkaf046.","journal-title":"Burns Trauma"},{"issue":"1","key":"678_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"678_CR62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00377-2021","volume":"58","author":"A Birnhuber","year":"2021","unstructured":"Birnhuber A, Flie\u00dfer E, Gorkiewicz G, Zacharias M, Seeliger B, David S, et al. Between inflammation and thrombosis: endothelial cells in COVID-19. Eur Respir J. 2021;58(3):2100377.","journal-title":"Eur Respir J"},{"issue":"11","key":"678_CR63","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.121.053547","volume":"144","author":"SJ Schunk","year":"2021","unstructured":"Schunk SJ, Triem S, Schmit D, Zewinger S, Sarakpi T, Becker E, et al. Interleukin-1\u03b1 is a central regulator of leukocyte-endothelial adhesion in myocardial infarction and in chronic kidney disease. Circulation. 2021;144(11):893\u2013908.","journal-title":"Circulation"},{"issue":"6","key":"678_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355\u201362.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"678_CR65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210562","volume":"219","author":"V Mysore","year":"2022","unstructured":"Mysore V, Tahir S, Furuhashi K, Arora J, Rosetti F, Cullere X, et al. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J Exp Med. 2022;219(5):e20210562.","journal-title":"J Exp Med"},{"issue":"10","key":"678_CR66","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s11427-021-2136-y","volume":"65","author":"Q Wang","year":"2022","unstructured":"Wang Q, Deng J, Sun J, Zhang H, Liu D, Gao C, et al. PDGFR kinase inhibitor protects against septic death via regulation of BTLA. Sci China Life Sci. 2022;65(10):1917\u201328.","journal-title":"Sci China Life Sci"},{"issue":"6","key":"678_CR67","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","volume":"9","author":"OJ McElvaney","year":"2021","unstructured":"McElvaney OJ, Curley GF, Rose-John S, McElvaney NG. Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med. 2021;9(6):643\u201354.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"678_CR68","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","volume":"23","author":"S Rose-John","year":"2023","unstructured":"Rose-John S, Jenkins BJ, Garbers C, Moll JM, Scheller J. Targeting IL-6 trans-signalling: past, present and future prospects. Nat Rev Immunol. 2023;23(10):666\u201381.","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"678_CR69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147566","volume":"132","author":"X Chen","year":"2022","unstructured":"Chen X, Hu J, Wang Y, Lee Y, Zhao X, Lu H, et al. The FoxO4\/DKK3 axis represses IFN-\u03b3 expression by Th1 cells and limits antimicrobial immunity. J Clin Invest. 2022;132(18):e147566.","journal-title":"J Clin Invest"},{"issue":"17","key":"678_CR70","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147593","volume":"6","author":"DK Gao","year":"2021","unstructured":"Gao DK, Salomonis N, Henderlight M, Woods C, Thakkar K, Grom AA, et al. IFN-\u03b3 is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome. JCI Insight. 2021;6(17):e147593.","journal-title":"JCI Insight"},{"issue":"1","key":"678_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6(1):402.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"678_CR72","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.immuni.2020.07.012","volume":"53","author":"D Chang","year":"2020","unstructured":"Chang D, Xing Q, Su Y, Zhao X, Xu W, Wang X, et al. The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced rorc transcription during T helper 17 cell differentiation. Immunity. 2020;53(3):614-26.e4.","journal-title":"Immunity"},{"issue":"1","key":"678_CR73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"10229","key":"678_CR74","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet"},{"issue":"8","key":"678_CR75","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.4049\/jimmunol.1900637","volume":"203","author":"M Mazer","year":"2019","unstructured":"Mazer M, Unsinger J, Drewry A, Walton A, Osborne D, Blood T, et al. IL-10 has differential effects on the innate and adaptive immune systems of septic patients. J Immunol. 2019;203(8):2088\u201399.","journal-title":"J Immunol"},{"issue":"1","key":"678_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024;9(1):61.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"678_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"678_CR78","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56.","journal-title":"Mil Med Res"},{"issue":"4","key":"678_CR79","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607\u201312.","journal-title":"Immunity"},{"issue":"10","key":"678_CR80","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3(10):944\u201350.","journal-title":"Nat Immunol"},{"issue":"5","key":"678_CR81","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41590-025-02136-4","volume":"26","author":"F Keramati","year":"2025","unstructured":"Keramati F, Leijte GP, Bruse N, Grondman I, Habibi E, Ruiz-Moreno C, et al. Systemic inflammation impairs myelopoiesis and interferon type I responses in humans. Nat Immunol. 2025;26(5):737\u201347.","journal-title":"Nat Immunol"},{"issue":"4","key":"678_CR82","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaci.2021.05.045","volume":"148","author":"K Jansen","year":"2021","unstructured":"Jansen K, Wirz OF, van de Veen W, Tan G, Mirer D, Sokolowska M, et al. Loss of regulatory capacity in Treg cells following rhinovirus infection. J Allergy Clin Immunol. 2021;148(4):1016-29.e16.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"678_CR83","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2019.11.005","volume":"51","author":"X Yang","year":"2019","unstructured":"Yang X, Cheng X, Tang Y, Qiu X, Wang Y, Kang H, et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity. 2019;51(6):983\u201396.","journal-title":"Immunity"},{"issue":"11","key":"678_CR84","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450\u201364.","journal-title":"Immunity"},{"key":"678_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaf050","volume":"13","author":"W Bi","year":"2025","unstructured":"Bi W, Wang R, Hou S, Liu W, Zhang H, Xu Z, et al. Alveolar epithelial type 2 cells in acute lung injury and acute respiratory distress syndrome: spatiotemporal fate and regulation. Burns Trauma. 2025;13:tkaf050.","journal-title":"Burns Trauma"},{"issue":"73","key":"678_CR86","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj5761","volume":"7","author":"F Li","year":"2022","unstructured":"Li F, Piattini F, Pohlmeier L, Feng Q, Rehrauer H, Kopf M. Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection. Sci Immunol. 2022;7(73):eabj5761.","journal-title":"Sci Immunol"},{"key":"678_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115382","volume":"208","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gao Z, Jiang F, Yan H, Yang B, He Q, et al. JAK-STAT signaling as an ARDS therapeutic target: status and future trends. Biochem Pharmacol. 2023;208:115382.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"678_CR88","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636\u201343.","journal-title":"Nat Med"},{"key":"678_CR89","doi-asserted-by":"crossref","unstructured":"Khan N, Kumar V, Li P, RAPIDS Study Group, Schlapbach LJ, Boyd AW, et al. Inhibiting Eph\/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis. Sci Transl Med. 2024;16(744):eadg5768.","DOI":"10.1126\/scitranslmed.adg5768"},{"issue":"1","key":"678_CR90","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13054-021-03803-2","volume":"25","author":"J Mesquida","year":"2021","unstructured":"Mesquida J, Caballer A, Cortese L, Vila C, Karadeniz U, Pagliazzi M, et al. Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit Care. 2021;25(1):381.","journal-title":"Crit Care"},{"issue":"2","key":"678_CR91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41581-020-00344-9","volume":"17","author":"DAC Messerer","year":"2021","unstructured":"Messerer DAC, Halbgebauer R, Nilsson B, Pavenst\u00e4dt H, Radermacher P, Huber-Lang M. Immunopathophysiology of trauma-related acute kidney injury. Nat Rev Nephrol. 2021;17(2):91\u2013111.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"678_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04040-3","volume":"26","author":"H Yang","year":"2025","unstructured":"Yang H, Chen Y, He J, Li Y, Feng Y. Advances in the diagnosis of early biomarkers for acute kidney injury: a literature review. BMC Nephrol. 2025;26(1):115.","journal-title":"BMC Nephrol"},{"issue":"2","key":"678_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021082","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. 2024;25(2):1082.","journal-title":"Int J Mol Sci"},{"key":"678_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.113141","volume":"230","author":"JX Zhang","year":"2022","unstructured":"Zhang JX, Yang Y, Huang H, Xie HB, Huang M, Jiang W, et al. TNF-\u03b1\/TNFR1 regulates the polarization of Kupffer cells to mediate trichloroethylene-induced liver injury. Ecotoxicol Environ Saf. 2022;230:113141.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"3","key":"678_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030716","volume":"14","author":"ENGDS Pereira","year":"2022","unstructured":"Pereira ENGDS, Araujo BP, Rodrigues KL, Silvares RR, Martins CSM, Flores EEI, et al. Simvastatin improves microcirculatory function in nonalcoholic fatty liver disease and downregulates oxidative and ALE-RAGE stress. Nutrients. 2022;14(3):716.","journal-title":"Nutrients"},{"issue":"2","key":"678_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/brx2.67","volume":"2","author":"R Wang","year":"2024","unstructured":"Wang R, Bi W, Huang S, Han Q, Deng J, Wang Z, et al. Recent advances in the pathogenesis, diagnosis, and treatment of sepsis\u2010associated encephalopathy. Brain-X. 2024;2(2):e67.","journal-title":"Brain-X"},{"key":"678_CR97","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","volume":"8","author":"TE Gofton","year":"2012","unstructured":"Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8:557\u201366.","journal-title":"Nat Rev Neurol"},{"key":"678_CR98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbi.2014.07.002","volume":"43","author":"M Michels","year":"2015","unstructured":"Michels M, Vieira AS, Vuolo F, Zapelini HG, Mendon\u00e7a B, Mina F, et al. The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain Behav Immun. 2015;43:54\u20139.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"678_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2110-5820-3-15","volume":"3","author":"R Sonneville","year":"2013","unstructured":"Sonneville R, Verdonk F, Rauturier C, Klein IF, Wolff M, Annane D, et al. Understanding brain dysfunction in sepsis. Ann Intensive Care. 2013;3(1):15.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"678_CR100","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s12035-016-0356-7","volume":"55","author":"LG Danielski","year":"2018","unstructured":"Danielski LG, Giustina AD, Badawy M, Barichello T, Quevedo J, Dal-Pizzol F, et al. Brain barrier breakdown as a cause and consequence of neuroinflammation in sepsis. Mol Neurobiol. 2018;55(2):1045\u201353.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"678_CR101","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00000658-199208000-00002","volume":"216","author":"EA Deitch","year":"1992","unstructured":"Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216(2):117\u201334.","journal-title":"Ann Surg"},{"issue":"4","key":"678_CR102","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/shk.0b013e31805569df","volume":"28","author":"JA Clark","year":"2007","unstructured":"Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the \u201cmotor\u201d of critical illness. Shock. 2007;28(4):384\u201393.","journal-title":"Shock"},{"issue":"6","key":"678_CR103","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.surge.2012.03.003","volume":"10","author":"EA Deitch","year":"2012","unstructured":"Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10(6):350\u20136.","journal-title":"Surgeon"},{"issue":"2","key":"678_CR104","first-page":"128","volume":"22","author":"A Reintam Blaser","year":"2016","unstructured":"Reintam Blaser A, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU. Curr Opin Crit Care. 2016;22(2):128\u201341.","journal-title":"Curr Opin Crit Care"},{"issue":"11","key":"678_CR105","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"issue":"4","key":"678_CR106","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625\u201338.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"678_CR107","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2213-2600(23)00468-X","volume":"12","author":"M Shankar-Hari","year":"2024","unstructured":"Shankar-Hari M, Calandra T, Soares MP, Bauer M, Wiersinga WJ, Prescott HC, et al. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies. Lancet Respir Med. 2024;12(4):323\u201336.","journal-title":"Lancet Respir Med"},{"issue":"24","key":"678_CR108","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154093","volume":"6","author":"MJ Nash","year":"2021","unstructured":"Nash MJ, Dobrinskikh E, Newsom SA, Messaoudi I, Janssen RC, Aagaard KM, et al. Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring. JCI Insight. 2021;6(24):e154093.","journal-title":"JCI Insight"},{"issue":"2","key":"678_CR109","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"678_CR110","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard-2024-225854","volume":"83","author":"S Bindoli","year":"2024","unstructured":"Bindoli S, De Matteis A, Mitrovic S, Fautrel B, Carmona L, De Benedetti F. Efficacy and safety of therapies for Still\u2019s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR\/PReS guidelines for the management of Still\u2019s disease. Ann Rheum Dis. 2024;83(12):1731\u201347.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"678_CR111","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12936-018-2377-3","volume":"17","author":"I Hennessee","year":"2018","unstructured":"Hennessee I, Guilavogui T, Camara A, Halsey ES, Marston B, McFarland D, et al. Adherence to Ebola-specific malaria case management guidelines at health facilities in Guinea during the West African Ebola epidemic. Malar J. 2018;17(1):230.","journal-title":"Malar J"},{"issue":"7","key":"678_CR112","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7(7):416\u201326.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"678_CR113","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1016\/S2665-9913(21)00216-2","volume":"3","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Huet T, Cavalli G, Gori A, Kyprianou M, Pickkers P, et al. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol. 2021;3(10):e690\u20137.","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"678_CR114","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2021.01.024","volume":"147","author":"E Pontali","year":"2021","unstructured":"Pontali E, Volpi S, Signori A, Antonucci G, Castellaneta M, Buzzi D, et al. Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia. J Allergy Clin Immunol. 2021;147(4):1217\u201325.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"678_CR115","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50(4):1007\u201323.","journal-title":"Immunity"},{"issue":"6832","key":"678_CR116","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/35074114","volume":"410","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410(6832):1103\u20137.","journal-title":"Nature"},{"issue":"11","key":"678_CR117","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1084\/jem.20040708","volume":"200","author":"S Gibot","year":"2004","unstructured":"Gibot S, Kolopp-Sarda MN, B\u00e9n\u00e9 MC, Bollaert PE, Lozniewski A, Mory F, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004;200(11):1419\u201326.","journal-title":"J Exp Med"},{"issue":"10","key":"678_CR118","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991\u20135.","journal-title":"J Immunol"},{"issue":"7","key":"678_CR119","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00134-020-06109-z","volume":"46","author":"B Fran\u00e7ois","year":"2020","unstructured":"Fran\u00e7ois B, Wittebole X, Ferrer R, Mira JP, Dugernier T, Gibot S, et al. Nangibotide in patients with septic shock: a phase 2a randomized controlled clinical trial. Intensive Care Med. 2020;46(7):1425\u201337.","journal-title":"Intensive Care Med"},{"issue":"10","key":"678_CR120","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-2600(23)00158-3","volume":"11","author":"B Fran\u00e7ois","year":"2023","unstructured":"Fran\u00e7ois B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. Lancet Respir Med. 2023;11(10):894\u2013904.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"678_CR121","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm1419","volume":"12","author":"M Huber-Lang","year":"2006","unstructured":"Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12(6):682\u20137.","journal-title":"Nat Med"},{"issue":"12","key":"678_CR122","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","volume":"10","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar APJ, Witzenrath M, van Paassen P, Heunks LM, Mourvillier B, de Bruin S, et al. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(12):1137\u201346.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"678_CR123","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","volume":"192","author":"K Kitamura","year":"1993","unstructured":"Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192(2):553\u201360.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"678_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-019-0255-0","volume":"7","author":"A Blet","year":"2019","unstructured":"Blet A, Deniau B, Geven C, Sadoune M, Caillard A, Kounde P-R, et al. Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats. Intensive Care Med Exp. 2019;7(1):25.","journal-title":"Intensive Care Med Exp"},{"issue":"2","key":"678_CR125","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SHK.0000000000001103","volume":"50","author":"C Geven","year":"2018","unstructured":"Geven C, Bergmann A, Kox M, Pickkers P. Vascular effects of adrenomedullin and the anti-adrenomedullin antibody adrecizumab in sepsis. Shock. 2018;50(2):132\u201340.","journal-title":"Shock"},{"issue":"11","key":"678_CR126","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","volume":"47","author":"PF Laterre","year":"2021","unstructured":"Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, et al. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intensive Care Med. 2021;47(11):1284\u201394.","journal-title":"Intensive Care Med"},{"issue":"11","key":"678_CR127","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.molmed.2020.06.007","volume":"26","author":"R Clere-Jehl","year":"2020","unstructured":"Clere-Jehl R, Mariotte A, Meziani F, Bahram S, Georgel P, Helms J. JAK-STAT targeting offers novel therapeutic opportunities in sepsis. Trends Mol Med. 2020;26(11):987\u20131002.","journal-title":"Trends Mol Med"},{"issue":"4","key":"678_CR128","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/pathogens14040324","volume":"14","author":"A Jarneborn","year":"2025","unstructured":"Jarneborn A, Kopparapu PK, Jin T. The dual-edged sword: risks and benefits of JAK inhibitors in infections. Pathogens. 2025;14(4):324.","journal-title":"Pathogens"},{"key":"678_CR129","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12950-023-00332-3","volume":"20","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang X, Sun L, Gao G, Li Y. Tofacitinib reduces acute lung injury and improves survival in a rat model of sepsis by inhibiting the JAK-STAT\/NF-\u03baB pathway. J Inflamm. 2023;20:5.","journal-title":"J Inflamm"},{"issue":"1","key":"678_CR130","doi-asserted-by":"publisher","first-page":"10891","DOI":"10.1038\/s41598-020-67928-0","volume":"10","author":"A Jarneborn","year":"2020","unstructured":"Jarneborn A, Mohammad M, Engdahl C, Hu Z, Na M, Ali A, et al. Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice. Sci Rep. 2020;10(1):10891.","journal-title":"Sci Rep"},{"key":"678_CR131","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med. 2021;384:795\u2013807.","journal-title":"N Engl J Med"},{"issue":"9","key":"678_CR132","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/infdis\/jiac040","volume":"225","author":"M Krzyzowska","year":"2022","unstructured":"Krzyzowska M, Jarneborn A, Thorn K, Eriksson K, Jin T. Tofacitinib treatment in primary herpes simplex encephalitis interferes with antiviral response. J Infect Dis. 2022;225(9):1545\u201353.","journal-title":"J Infect Dis"},{"key":"678_CR133","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6636621","volume":"2021","author":"M Yang","year":"2021","unstructured":"Yang M, Fang JT, Zhang NS, Qin LJ, Zhuang YY, Wang WW, et al. Caspase-1-inhibitor AC-YVAD-CMK inhibits pyroptosis and ameliorates acute kidney injury in a model of sepsis. Biomed Res Int. 2021;2021:6636621.","journal-title":"Biomed Res Int"},{"issue":"5","key":"678_CR134","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/eji.202048937","volume":"51","author":"Q Chen","year":"2021","unstructured":"Chen Q, Zheng J, Wang D, Liu Q, Kang L, Gao X, et al. Nitrosonisoldipine is a selective inhibitor of inflammatory caspases and protects against pyroptosis and related septic shock. Eur J Immunol. 2021;51(5):1234\u201345.","journal-title":"Eur J Immunol"},{"issue":"2","key":"678_CR135","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","volume":"179","author":"F Fang","year":"2019","unstructured":"Fang F, Zhang Y, Tang J, Lunsford LD, Li T, Tang R, et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(2):213\u201323.","journal-title":"JAMA Intern Med"},{"key":"678_CR136","doi-asserted-by":"crossref","unstructured":"REMAP-CAP Investigators, Angus DC. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : the REMAP-CAP Corticosteroid Domain Randomized Clinical Trial. Intensive Care Med. 2025;51(4):665\u201380.","DOI":"10.1007\/s00134-025-08046-1"},{"issue":"21","key":"678_CR137","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. 2023;388(21):1931\u201341.","journal-title":"N Engl J Med"},{"issue":"8010","key":"678_CR138","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-07282-7","volume":"629","author":"JP Auger","year":"2024","unstructured":"Auger JP, Zimmermann M, Faas M, Stifel U, Chambers D, Krishnacoumar B, et al. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature. 2024;629(8010):184\u201392.","journal-title":"Nature"},{"issue":"14","key":"678_CR139","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/cells11142126","volume":"11","author":"L Rocamora-Reverte","year":"2022","unstructured":"Rocamora-Reverte L, Villunger A, Wiegers GJ. Cell-specific immune regulation by glucocorticoids in murine models of infection and inflammation. Cells. 2022;11(14):2126.","journal-title":"Cells"},{"issue":"2","key":"678_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/cc12514","volume":"17","author":"PE Marik","year":"2013","unstructured":"Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response!. Crit Care. 2013;17(2):305.","journal-title":"Crit Care"},{"issue":"9","key":"678_CR141","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"678_CR142","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","volume":"12","author":"N Heming","year":"2024","unstructured":"Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, Quenot J-P, et al. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Lancet Respir Med. 2024;12(5):366\u201374.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"678_CR143","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med. 2024;52(5):e219\u201333.","journal-title":"Crit Care Med"},{"issue":"10","key":"678_CR144","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s00134-025-08044-3","volume":"51","author":"D Annane","year":"2025","unstructured":"Annane D, Briegel J, Seymour CW. Corticosteroids in sepsis: certainties and shadows. Intensive Care Med. 2025;51(10):1890\u20133.","journal-title":"Intensive Care Med"},{"key":"678_CR145","doi-asserted-by":"crossref","unstructured":"Annane D, Briegel J, Granton D, Bellissant PE, Keh D, Kupfer Y, et al. Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev. 2025;6(6):CD002243.","DOI":"10.1002\/14651858.CD002243.pub5"},{"issue":"9","key":"678_CR146","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","volume":"27","author":"C Ronco","year":"2003","unstructured":"Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27(9):792\u2013801.","journal-title":"Artif Organs"},{"issue":"1","key":"678_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0530-y","volume":"9","author":"PM Honore","year":"2019","unstructured":"Honore PM, Hoste E, Moln\u00e1r Z, Jacobs R, Joannes-Boyau O, Malbrain ML, et al. Cytokine removal in human septic shock: where are we and where are we going?. Ann Intensive Care. 2019;9(1):56.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"678_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04044-7","volume":"26","author":"G Eden","year":"2022","unstructured":"Eden G, Schmidt JJ, B\u00fcttner S, K\u00fcmpers P, Hafer C, Rovas A, et al. Safety and efficacy of the Seraph\u00ae 100 Microbind\u00ae affinity blood filter to remove bacteria from the blood stream: results of the first in human study. Crit Care. 2022;26(1):181.","journal-title":"Crit Care"},{"issue":"10","key":"678_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187015","volume":"12","author":"D Sch\u00e4dler","year":"2017","unstructured":"Sch\u00e4dler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS One. 2017;12(10):e0187015.","journal-title":"PLoS ONE"},{"issue":"1","key":"678_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2588-1","volume":"23","author":"WP Brouwer","year":"2019","unstructured":"Brouwer WP, Duran S, Kuijper M, Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317.","journal-title":"Crit Care"},{"issue":"8","key":"678_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220444","volume":"14","author":"ME Broman","year":"2019","unstructured":"Broman ME, Hansson F, Vincent JL, Bodelsson M. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS One. 2019;14(8):e0220444.","journal-title":"PLoS ONE"},{"issue":"4","key":"678_CR152","first-page":"3839","volume":"13","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Pan J, Zhang C. The application value of oXiris-endotoxin adsorption in sepsis. Am J Transl Res. 2021;13(4):3839\u201344.","journal-title":"Am J Transl Res"},{"issue":"5","key":"678_CR153","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98960","volume":"3","author":"B Francois","year":"2018","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3(5):e98960.","journal-title":"JCI Insight"},{"issue":"6","key":"678_CR154","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.189150","volume":"10","author":"M Shankar-Hari","year":"2025","unstructured":"Shankar-Hari M, Francois B, Remy KE, Gutierrez C, Pastores S, Daix T, et al. A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19. JCI Insight. 2025;10(6):e189150.","journal-title":"JCI Insight"},{"key":"678_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101523","volume":"54","author":"AA Achuthan","year":"2021","unstructured":"Achuthan AA, Lee KMC, Hamilton JA. Targeting GM-CSF in inflammatory and autoimmune disorders. Semin Immunol. 2021;54:101523.","journal-title":"Semin Immunol"},{"key":"678_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1130214","volume":"14","author":"I Joshi","year":"2023","unstructured":"Joshi I, Carney WP, Rock EP. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Front Immunol. 2023;14:1130214.","journal-title":"Front Immunol"},{"issue":"8","key":"678_CR157","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41577-020-0357-7","volume":"20","author":"FM Lang","year":"2020","unstructured":"Lang FM, Lee KM, Teijaro JR, Becher B, Hamilton JA. GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches. Nat Rev Immunol. 2020;20(8):507\u201314.","journal-title":"Nat Rev Immunol"},{"key":"678_CR158","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB. Regulation of interferon\u2010\u03b3 during innate and adaptive immune responses. Adv Immunol. 2007;96:41\u2013101.","journal-title":"Adv Immunol"},{"issue":"10","key":"678_CR159","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","volume":"20","author":"JS Lee","year":"2020","unstructured":"Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20(10):585\u20136.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"678_CR160","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00299-20","volume":"34","author":"S Ramasamy","year":"2021","unstructured":"Ramasamy S, Subbian S. Critical determinants of cytokine storm and type i interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. 2021;34(3):e00299-20.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"678_CR161","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.CIR-21-0515","volume":"10","author":"N Budimir","year":"2022","unstructured":"Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S. Reversing T-cell exhaustion in cancer: lessons learned from PD-1\/PD-L1 immune checkpoint blockade. Cancer Immunol Res. 2022;10(2):146\u201353.","journal-title":"Cancer Immunol Res"},{"issue":"24","key":"678_CR162","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146701","volume":"6","author":"C Loretelli","year":"2021","unstructured":"Loretelli C, Abdelsalam A, D\u2019Addio F, Ben Nasr M, Assi E, Usuelli V, et al. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response. JCI Insight. 2021;6(24):e146701.","journal-title":"JCI Insight"},{"key":"678_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101480","volume":"52","author":"KE Pauken","year":"2021","unstructured":"Pauken KE, Torchia JA, Chaudhri A, Sharpe AH, Freeman GJ. Emerging concepts in PD-1 checkpoint biology. Semin Immunol. 2021;52:101480.","journal-title":"Semin Immunol"},{"key":"678_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.624279","volume":"11","author":"Y Nakamori","year":"2021","unstructured":"Nakamori Y, Park EJ, Shimaoka M. Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1\/PD-L1 pathway. Front Immunol. 2021;11:624279.","journal-title":"Front Immunol"},{"issue":"21","key":"678_CR165","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.7150\/thno.47982","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Wan M, Lyon CJ, Hu TY. Nanomedicine therapies modulating macrophage dysfunction: a potential strategy to attenuate cytokine storms in severe infections. Theranostics. 2020;10(21):9591\u2013600.","journal-title":"Theranostics"},{"issue":"6658","key":"678_CR166","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/37022","volume":"390","author":"RE Voll","year":"1997","unstructured":"Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997;390(6658):350\u20131.","journal-title":"Nature"},{"key":"678_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718191","volume":"12","author":"PV van Heerden","year":"2021","unstructured":"van Heerden PV, Abutbul A, Sviri S, Zlotnick E, Nama A, Zimro S, et al. Apoptotic cells for therapeutic use in cytokine storm associated with sepsis- a phase Ib clinical trial. Front Immunol. 2021;12:718191.","journal-title":"Front Immunol"},{"issue":"11","key":"678_CR168","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/stem.2891","volume":"36","author":"D Perlee","year":"2018","unstructured":"Perlee D, van Vught LA, Scicluna BP, Maag A, Lutter R, Kemper EM, et al. Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial. Stem Cells. 2018;36(11):1778\u201388.","journal-title":"Stem Cells"},{"issue":"2","key":"678_CR169","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jointm.2023.12.002","volume":"4","author":"X Guan","year":"2024","unstructured":"Guan X, Chen D, Xu Y. Clinical practice guidelines for nutritional assessment and monitoring of adult ICU patients in China. J Intensive Med. 2024;4(2):137\u201359.","journal-title":"J Intensive Med"},{"key":"678_CR170","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077979","volume":"388","author":"J Reignier","year":"2025","unstructured":"Reignier J, Rice TW, Arabi YM, Casaer M. Nutritional support in the ICU. BMJ. 2025;388:e077979.","journal-title":"BMJ"},{"issue":"7","key":"678_CR171","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/jpen.2364","volume":"46","author":"ML Bechtold","year":"2022","unstructured":"Bechtold ML, Brown PM, Escuro A, Grenda B, Johnston T, Kozeniecki M, et al. When is enteral nutrition indicated? JPEN J Parenter Enteral Nutr. 2022;46(7):1470\u201396.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"678_CR172","doi-asserted-by":"publisher","first-page":"1370472","DOI":"10.3389\/fnut.2024.1370472","volume":"11","author":"F Xu","year":"2024","unstructured":"Xu F, Xu J, Ma J, Xu W, Gu S, Lu G, et al. Early versus delayed enteral nutrition in ICU patients with sepsis: a propensity score-matched analysis based on the MIMIC-IV database. Front Nutr. 2024;11:1370472.","journal-title":"Front Nutr"},{"issue":"3","key":"678_CR173","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v14.i3.102834","volume":"14","author":"V Yanamaladoddi","year":"2025","unstructured":"Yanamaladoddi V, D\u2019Cunha H, Charley E, Kumar V, Sohal A, Youssef W. Early enteral nutrition in critically-ill patients. World J Crit Care Med. 2025;14(3):102834.","journal-title":"World J Crit Care Med"},{"issue":"Suppl 2","key":"678_CR174","first-page":"S174","volume":"38","author":"DM Fell","year":"2023","unstructured":"Fell DM, Bitetto EA, Skillman HE. Timing of enteral nutrition and parenteral nutrition in the PICU. Nutr Clin Pract. 2023;38(Suppl 2):S174-212.","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"678_CR175","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","volume":"16","author":"SR Bornstein","year":"2020","unstructured":"Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020;16(6):297\u20138.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"678_CR176","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C. Lactate: a key regulator of the immune response. Immunity. 2025;58(3):535\u201354.","journal-title":"Immunity"},{"issue":"8","key":"678_CR177","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04490-0","volume":"79","author":"J Liu","year":"2022","unstructured":"Liu J, Zhou G, Wang X, Liu D. Metabolic reprogramming consequences of sepsis: adaptations and contradictions. Cell Mol Life Sci. 2022;79(8):456.","journal-title":"Cell Mol Life Sci"},{"key":"678_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102171","volume":"48","author":"N Pescador","year":"2021","unstructured":"Pescador N, Francisco V, V\u00e1zquez P, Esquinas EM, Gonz\u00e1lez-P\u00e1ramos C, Valdecantos MP, et al. Metformin reduces macrophage HIF1\u03b1-dependent proinflammatory signaling to restore brown adipocyte function in vitro. Redox Biol. 2021;48:102171.","journal-title":"Redox Biol"},{"issue":"33","key":"678_CR179","doi-asserted-by":"publisher","first-page":"20348","DOI":"10.1074\/jbc.M115.662114","volume":"290","author":"B Kelly","year":"2015","unstructured":"Kelly B, Tannahill GM, Murphy MP, O\u2019Neill LA. Metformin inhibits the production of reactive oxygen species from NADH: ubiquinone oxidoreductase to limit induction of interleukin-1\u03b2 (IL-1\u03b2) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. J Biol Chem. 2015;290(33):20348\u201359.","journal-title":"J Biol Chem"},{"issue":"6","key":"678_CR180","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000221429.94591.72","volume":"47","author":"Y Hattori","year":"2006","unstructured":"Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokine-induced nuclear factor \u03baB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension. 2006;47(6):1183\u20138.","journal-title":"Hypertension"},{"issue":"9","key":"678_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23820","volume":"38","author":"UN Das","year":"2024","unstructured":"Das UN. Why thiamine alone is inadequate and how essential fatty acids can augment recovery from sepsis?. J Biochem Mol Toxicol. 2024;38(9):e23820.","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"678_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060934","volume":"60","author":"UN Das","year":"2024","unstructured":"Das UN. The dysregulation of essential fatty acid (EFA) metabolism may be a factor in the pathogenesis of sepsis. Medicina Kaunas. 2024;60(6):934.","journal-title":"Medicina Kaunas"},{"issue":"9","key":"678_CR183","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/biom13091332","volume":"13","author":"UN Das","year":"2023","unstructured":"Das UN. Infection, inflammation, and immunity in sepsis. Biomolecules. 2023;13(9):1332.","journal-title":"Biomolecules"},{"issue":"6","key":"678_CR184","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nri3843","volume":"15","author":"SS Evans","year":"2015","unstructured":"Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15(6):335\u201349.","journal-title":"Nat Rev Immunol"},{"key":"678_CR185","doi-asserted-by":"publisher","first-page":"1215686","DOI":"10.3389\/fphys.2023.1215686","volume":"14","author":"A Markota","year":"2023","unstructured":"Markota A, Kalamar \u017d, Fluher J, Pirkmajer S. Therapeutic hyperthermia for the treatment of infection-a narrative review. Front Physiol. 2023;14:1215686.","journal-title":"Front Physiol"},{"key":"678_CR186","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s44231-025-00084-z","volume":"5","author":"C Meng","year":"2025","unstructured":"Meng C, Sun J, Miao G. Temperature management in critically ill patients. Intensiv Care Res. 2025;5:75\u20137.","journal-title":"Intensiv Care Res"},{"issue":"7","key":"678_CR187","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/aas.14254","volume":"67","author":"TS Itenov","year":"2023","unstructured":"Itenov TS, Kromann ME, Ostrowski SR, Bestle MH, Mohr T, Gyldensted L, et al. Mild induced hypothermia and coagulation and platelet function in patients with septic shock: secondary outcome of a randomized trial. Acta Anaesthesiol Scand. 2023;67(7):909\u201317.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"21","key":"678_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111411","volume":"25","author":"TG Paranga","year":"2024","unstructured":"Paranga TG, Mitu I, Pavel-Tanasa M, Rosu MF, Miftode IL, Constantinescu D, et al. Cytokine storm in COVID-19: exploring IL-6 signaling and cytokine-microbiome interactions as emerging therapeutic approaches. Int J Mol Sci. 2024;25(21):11411.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"678_CR189","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797\u2013808.","journal-title":"N Engl J Med"},{"issue":"3","key":"678_CR190","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/10600280211021103","volume":"56","author":"D Ragoonanan","year":"2022","unstructured":"Ragoonanan D, Allen B, Cannon C, Rottman-Pietrzak K, Bello A. Comparison of early versus late initiation of hydrocortisone in patients with septic shock in the ICU setting. Ann Pharmacother. 2022;56(3):264\u201370.","journal-title":"Ann Pharmacother"},{"issue":"23","key":"678_CR191","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","volume":"41","author":"PM Ridker","year":"2020","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Libby P. Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis. Eur Heart J. 2020;41(23):2153\u201363.","journal-title":"Eur Heart J"},{"issue":"1","key":"678_CR192","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01374-y","volume":"20","author":"QX Rong","year":"2021","unstructured":"Rong QX, Wang F, Guo ZX, Hu Y, An SN, Luo M, et al. GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer\/T cell lymphoma. Mol Cancer. 2021;20(1):80.","journal-title":"Mol Cancer"},{"key":"678_CR193","doi-asserted-by":"crossref","unstructured":"The REMAP-CAP Investigators. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Apr 22;384(16):1491\u2013502.","DOI":"10.1056\/NEJMoa2100433"},{"issue":"3","key":"678_CR194","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","volume":"8","author":"P Sinha","year":"2020","unstructured":"Sinha P, Delucchi KL, McAuley DF, O\u2019Kane CM, Matthay MA, Calfee CS. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med. 2020;8(3):247\u201357.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"678_CR195","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/thoraxjnl-2017-211090","volume":"73","author":"K Delucchi","year":"2018","unstructured":"Delucchi K, Famous KR, Ware LB, Parsons PE, Thompson BT, Calfee CS. Stability of ARDS subphenotypes over time in two randomised controlled trials. Thorax. 2018;73(5):439\u201345.","journal-title":"Thorax"},{"issue":"1","key":"678_CR196","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1164\/rccm.201809-1808OC","volume":"200","author":"LD Bos","year":"2019","unstructured":"Bos LD, Scicluna BP, Ong DS, Cremer O, van Der Poll T, Schultz MJ. Understanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profiles. Am J Respir Crit Care Med. 2019;200(1):42\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"678_CR197","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076612","volume":"387","author":"KD Wick","year":"2024","unstructured":"Wick KD, Ware LB, Matthay MA. Acute respiratory distress syndrome. BMJ. 2024;387:e076612.","journal-title":"BMJ"},{"key":"678_CR198","unstructured":"The PANTHER investigators. PANTHER: statistical design appendix. URL: https:\/\/panthertrial.org\/assets\/images\/uploads\/doc\/PANTHER_Statistical_design_appendix_V1.0.docx. [ Accessed 14 September 2025]."}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00678-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-025-00678-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00678-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:53:15Z","timestamp":1772830395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40779-025-00678-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1186\/s40779-025-00678-0","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}